EyeGene Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 0.3416 million compared to KRW 2.21 million a year ago. Net loss was KRW 7,567.74 million compared to KRW 6,346.4 million a year ago.

Basic loss per share from continuing operations was KRW 352 compared to KRW 296 a year ago. Diluted loss per share from continuing operations was KRW 355. Basic loss per share was KRW 352 compared to KRW 296 a year ago.

Diluted loss per share was KRW 355.